combining vegf tkis with immunotherapy for rcc
Published 5 years ago • 91 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
1:28
dr. sznol on factors to consider when combining vegf tkis/immunotherapy in rcc
-
1:31
combining immunotherapy with vegf inhibitors to treat kidney cancer
-
8:07
vegf tki immunotherapy combinations for mrcc
-
1:15
dr. figlin on toxicity profile of immunotherapy/vegf tki combinations in rcc
-
0:58
next steps for combination immunotherapies for rcc
-
5:15
favorable-risk rcc: frontline vegf tki/io combinations
-
1:55
dr. kim on combining immunotherapy and tkis in metastatic rcc
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:45
combined blockade of vegf and pd-1 signaling in rcc
-
5:11
selecting immunotherapy versus vegf tki for mrcc
-
4:27
vegf-tki therapy in first-line mrcc
-
3:39
anti-vegf/immunotherapy combinations in kidney cancer
-
1:18
dr. figlin on considerations for combining tkis and immunotherapy in rcc
-
2:07
dr. mcdermott on tki/immunotherapy combinations in rcc
-
0:31
immunotherapy combined with new treatments suggested as the future of arcc therapy
-
1:44
selecting immunotherapy for rcc
-
1:46
dr. gupta on vegf inhibitors combined with immunotherapy in kidney cancer
-
4:09
favorable-risk rcc: options for vegf tki monotherapy
-
1:37
dr. choueiri on synergy between immunotherapy and vegf inhibitors in rcc